Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

With more than 71 million people chronically infected, hepatitis C virus (HCV) is one of the leading causes of liver disease and hepatocellular carcinoma. While efficient antiviral therapies have entered clinical standard of care, the development of a protective vaccine is still elusive. Recent stud...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Immunol
Main Authors: Wrensch, Florian, Crouchet, Emilie, Ligat, Gaetan, Zeisel, Mirjam B., Keck, Zhen-Yong, Foung, Steven K. H., Schuster, Catherine, Baumert, Thomas F.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Immunology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021501/
https://ncbi.nlm.nih.gov/pubmed/29977246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.01436
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki